Cart
sales@molnova.com
HCV NS4A Protein (22-33) (FDA strain)
CAS No. ———
HCV NS4A Protein (22-33) (FDA strain)( ——— )
Catalog No. M41260 CAS No. ———
HCV NS4A Protein (22-33) (FDA strain)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHCV NS4A Protein (22-33) (FDA strain)
-
NoteResearch use only, not for human use.
-
Brief DescriptionHCV NS4A Protein (22-33) (FDA strain)
-
DescriptionHCV NS4A Protein (22-33) (FDA strain)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1213.54
-
Molecular FormulaC54H98N15O14S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PNU-177864
dopamine D3 receptor antagonist.
-
Cerdulatinib hydroch...
Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively.
-
neo-gambogic acid
Neogambogic acid an active ingredient in garcinia can inhibit the growth of some solid tumors and result in an anticancer effect it may be responsible for the inhibition of proliferation of human breast cancer cell line MCF-7 cells.
